Page 13 - Milk and Medicine חלב ורפואה

12 1 ‫החלב והרפואה | גליון‬
Malcata FX: Invited review: physiological properties of
bioactive peptides obtained from whey proteins. J Dairy Sci
2010;93:437–455.
14. Nilsson M, Stenberg M, Frid AH, Holst JJ, Björck IME:
Glycemia and insulinemia in healthy subjects after lactose-
equivalent meals of milk and other food proteins: the
role of plasma amino acids and incretins. Am J Clin Nutr
2004;80(5):1246–1253.
15. Nilsson M, Holst JJ, Björck IM: Metabolic effects of amino
acid mixtures and whey protein in healthy subjects:
studies using glucose-equivalent drinks. Am J Clin Nutr
2007;85(4):996–1004.
16. Mortensen LS, Hartvigsen ML, Brader LJ, Astrup A,
Schrezenmeir J, Holst JJ, Thomsen C, Hermansen K:
Differential effects of protein quality on postprandial lipemia
in response to a fat-rich meal in type 2 diabetes: comparison
of whey, casein, gluten, and cod protein. Am J Clin Nutr 2009;
90:41–48
17. Muro Urista C, Alvarez Fernandez R, Riera Rodriguez F,
Arana Cuenca A, Tellez Jurado A: Review: Production and
functionality of active peptides from milk. Food Sci Technol
Int 2011; 17:293–317.
18. Boirie Y, Dangin M, Gachon P, Vasson MP, Maubois JL,
Beaufrère B: Slow and fast dietary proteins differently
modulate postprandial protein accretion. Proc Natl Acad Sci
USA 1997; 94(26):14930–14935.
19. Frid AH, Nilsson M, Holst JJ, Björck IME: Effect of whey on
blood glucose and insulin responses to composite breakfast
and lunch meals in type 2 diabetic subjects. Am J Clin Nutr
2005;82(1):69–75. (53)
20 . Claessens M, Saris WHM, Van Baak MA: Glucagon and
insulin responses after ingestion of different amounts of
intact and hydrolysed proteins. Br J Nutr 2008;100(1):61–69.
21. Nilsson M, Stenberg M, Frid AH, Holst JJ, Björck IME:
Glycemia and insulinemia in healthy subjects after lactose-
equivalent meals of milk and other food proteins: the role
of plasma amino acids and incretins. Am J Clin Nutr 2004;
80(5):1246–1253.
22. Nilsson M, Holst JJ, Björck IM: Metabolic effects of amino
acid mixtures and whey protein in healthy subjects:
studies using glucose-equivalent drinks. Am J Clin Nutr
2007;85(4):996–1004.
23. Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson
GH: Effect of premeal consumption of whey protein and
its hydrolysate on food intake and postmeal glycemia and
insulin responses in young adults. Am J Clin Nutr 2010;
91(4):966–975.
24. Claessens M, Calame W, Siemensma AD, Van Baak MA,
Saris WHM: The effect of different protein hydrolysate/
carbohydrate mixtures on postprandial glucagon and insulin
responses in healthy subjects. Eur J Clin Nutr 2009;63(1):48–
56.
25. Pal S, Ellis V: The acute effects of four protein meals on
insulin, glucose, appetite and energy intake in lean men. Br J
Nutr 2010, 104(8):1241–1248.
26. Petersen BL, Ward LS, Bastian ED, Jenkins AL, Campbell
J, Vuksan V: A whey protein supplement decreases post-
prandial glycemia. Nutr J 2009; 8:47.
27. Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones
KL, et al: Effects of a protein preload on gastric emptying,
glycemia, and gut hormones after a carbohydrate meal
in diet-controlled type 2 diabetes. Diabetes Care 2009;
32(9):1600–1602.
28. Manders RJF, Praet SFE, Vikström MH, Saris WHM, Van
Loon LJC: Protein hydrolysate co-ingestion does not
modulate 24 h glycemic control in long-standing type 2
diabetes patients. Eur J Clin Nutr 2009;63(1):121–126.
29. Manders RJF, Praet SFE, Meex RCR, Koopman R, De Roos
AL, Wagenmakers AJM, et al: Protein hydrolysate/leucine
co-ingestion reduces the prevalence of hyperglycemia in
type 2 diabetic patients. Diabetes Care 2006; 29(12):2721–
2722.
30. Gunnarsson PT, Winzell MS, Deacon CF, Larsen MO, Jelic K,
Carr RD, Ahren B: Glucose-induced incretin hormone release
and inactivation are differently modulated by oral fat and
protein in mice. Endocrinology 2006, 147:3173–3180.
31. Takasaki K, Nakajima T, Ueno K, Nomoto Y, Higo K: Effects of
combination treatment with dipeptidyl peptidase IV inhibitor
and sulfonylurea on glucose levels in rats. J Pharmacol Sci
2004;95:291–293.
32. Pal S, Ellis V, Dhaliwal S: Effects of whey protein isolate on
body composition, lipids, insulin and glucose in overweight
and obese individuals. Br J Nutr 2010, 104(5):716–723.
33. Jackson KG, Poppitt SD, Minihane AM: Postprandial
lipemia and cardiovascular disease risk: Interrelationships
between dietary, physiological and genetic determinants.
Atherosclerosis 2012; 220(1):22–33.
34. Cohen JC: Protein ingestion does not affect postprandial
lipaemia or chylomicron-triglyceride clearance. Eur J Clin
Nutr 1989, 43(7):497–499.
35. Westphal S, Kästner S, Taneva E, Leodolter A, Dierkes J,
Luley C: Postprandial lipid and carbohydrate responses after
the ingestion of a casein-enriched mixed meal. Am J Clin
Nutr 2004;80(2):284–290.
36. Westphal S, Taneva E, Kästner S, Martens-Lobenhoffer
J, Bode-Böger S, Kropf S, et al: Endothelial dysfunction
induced by postprandial lipemia is neutralized by addition of
proteins to the fatty meal. Atherosclerosis 2006, 185(2):313–
319.
37. Pal S, Ellis V, Ho S: Acute effects of whey protein isolate on
cardiovascular risk factors in overweight, post-menopausal
women. Atherosclerosis 2010; 212(1):339–344.
38. Brader L, Holm L, Mortensen L, Thomsen C, Astrup A, Holst
JJ, et al: Acute effects of casein on postprandial lipemia and
incretin responses in type 2 diabetic subjects. Nutr Metab
Cardiovasc Dis 2010;20(2):101–109.
39. Holmer-Jensen J, Hartvigsen ML, Mortensen LS, Astrup A,
De Vrese M, Holst JJ, et al: Acute differential effects of milk-
derived dietary proteins on postprandial lipaemia in obese
non-diabetic subjects. Eur J Clin Nutr 2012, 66(1):32–38.
40. Gouni-Berthold I, Schulte DM, Krone W, Lapointe J-F,
Lemieux P, Predel H-G, et al: The whey fermentation product
malleable protein matrix decreases TAG concentrations
in patients with the metabolic syndrome: a randomised
placebo-controlled trial. Br J Nutr 2012; 107(11):1694–1706
41. McGregor RA, Poppitt SD: Milk protein for improved
metabolic health: a review of the evidence. Nutrition
& Metabolism 2013;10:46. for oral delivery of
chemotherapeutic drugs. Nanomed: NBM 2010;6:119-26.
14. Bar-Zeev M, Assaraf YG, Livney YD. β-casein nanovehicles
for oral delivery of chemotherapeutic Drug combinations
overcoming P-glycoprotein-mediated multidrug resistance in
human gastric cancer cells. Oncotarget 2016;7(17):
23322- 34.